Head-to-head · Cost-Efficiency Index
Queen RX vs altRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Queen RX
Cost-first shoppers who want a low one-time cost to try a GLP-1 without committing to a monthly subscription.
Visit Queen RXaltRX
Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires.
Visit altRXThe verdict
Queen RX takes it, leading the Cost-Efficiency Index 71 to 70. Queen RX sells one flat bundle covering whichever of semaglutide, tirzepatide, or liraglutide a patient is prescribed: $299 as a one-time purchase for a virtual consult, 3 months of medication, and supplies. altRX still earns a C — Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Queen RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Queen RX | altRX |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $100/mo (starting dose, bundle, compounded) | $89/mo (all doses, promotional rate, plus a separate fee, compounded) |
| Tirzepatide / mo | $100/mo (bundle, compounded) | $149/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $1,200 | $1,068 |
| Tirzepatide / yr (modeled) | $1,200 | $1,788 |
| Coverage | 45 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #82 | #85 |
Queen RX
71/100Where the value is
- Full refund if the physician determines you can't be prescribed anything
- No subscription or membership fee — a single $299 purchase covers a full 3-month course including supplies
- Works out to one of the lower per-month equivalents in this batch when averaged over the 3-month term
The tradeoffs
- Not actually a monthly price — it's a one-time $299 purchase per 3-month term; there is no month-to-month billing option at all
- No price differentiation between semaglutide, tirzepatide, and liraglutide — all fall under the same $299 bundle regardless of which drug is prescribed or its dose
altRX
70/100Where the value is
- Same price at every dose — titrating up does not raise the monthly cost, unlike per-mg-tiered competitors
- No membership fee, no insurance required; price stated to be all-in (consultation, dosing plan, medication, free delivery, clinician support)
- LegitScript certified
The tradeoffs
- The advertised $89/$149 prices are an explicitly time-limited promotion with a live countdown on the page — the standing price is roughly double, and a naive reading of the headline as a stable price would be wrong within about a week of this research
- No compounding pharmacy is individually named, only '503A compounding pharmacies within the altRx network'
Regulatory note: the FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx in June 2026. We still list and link to altRX; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.